financetom
Business
financetom
/
Business
/
BRIEF-Tata Group Considers Buying Disney's Stake In Tata Play- ET Now
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Tata Group Considers Buying Disney's Stake In Tata Play- ET Now
Mar 14, 2024 5:48 AM

March 14 (Reuters) -

* TATA GROUP CONSIDERS BUYING DISNEY'S STAKE IN TATA PLAY-

ET NOW

Source text: [https://bit.ly/4cisuOI]

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google No Longer Claims Carbon Neutrality in Environmental Report
Google No Longer Claims Carbon Neutrality in Environmental Report
Jul 8, 2024
08:46 AM EDT, 07/08/2024 (MT Newswires) -- In what it called an evolution of its strategy that began in 2023, Alphabet's (GOOG) Google ( GOOG ) is no longer maintaining its operational carbon neutrality, the company said in its latest environmental report. We're instead focusing on accelerating an array of carbon solutions and partnerships that will help us work toward...
--Google No Longer Claims Carbon Neutrality in Environmental Report
--Google No Longer Claims Carbon Neutrality in Environmental Report
Jul 8, 2024
08:37 AM EDT, 07/08/2024 (MT Newswires) -- Price: 190.90, Change: -1.07, Percent Change: -0.55 ...
Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown
Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown
Jul 8, 2024
08:44 AM EDT, 07/08/2024 (MT Newswires) -- Aerovate Therapeutics ( AVTE ) said Monday it will consider strategic alternatives following its announcement that it was stopping enrollment and shutting down the phase 3 portion of its Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial and the long-term extension study. The company said it sought the assistance of Wedbush PacGrow in the...
NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment
NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment
Jul 8, 2024
08:45 AM EDT, 07/08/2024 (MT Newswires) -- NewAmsterdam Pharma ( NAMS ) said Monday it has completed patient enrollment for a phase 3 clinical trial evaluating the use of obicetrapib in combination with ezetimibe in adult patients with heterozygous familial hypercholesterolemia and/or either with or at risk of developing atherosclerotic cardiovascular disease. The 407 qualifying patients' low-density lipoproteins also are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved